T2 Biosystems PE Ratio 2013-2024 | TTOO
Current and historical p/e ratio for T2 Biosystems (TTOO) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. T2 Biosystems PE ratio as of March 11, 2026 is 0.00.
| T2 Biosystems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-03-10 | 0.00 | 0.00 | |
| 2024-09-30 | 1.97 | $-3.89 | 0.00 |
| 2024-06-30 | 5.34 | $-6.77 | 0.00 |
| 2024-03-31 | 3.00 | $-14.11 | 0.00 |
| 2023-12-31 | 6.28 | $-143.45 | 0.00 |
| 2023-09-30 | 22.10 | $-143.45 | 0.00 |
| 2023-06-30 | 7.10 | $-435.00 | 0.00 |
| 2023-03-31 | 46.00 | $-927.00 | 0.00 |
| 2022-12-31 | 142.00 | $-1,295.00 | 0.00 |
| 2022-09-30 | 565.00 | $-1,645.00 | 0.00 |
| 2022-06-30 | 810.00 | $-1,750.00 | 0.00 |
| 2022-03-31 | 2620.00 | $-1,650.00 | 0.00 |
| 2021-12-31 | 2580.00 | $-1,500.00 | 0.00 |
| 2021-09-30 | 4575.00 | $-1,500.00 | 0.00 |
| 2021-06-30 | 5950.00 | $-1,500.00 | 0.00 |
| 2021-03-31 | 8100.00 | $-1,550.00 | 0.00 |
| 2020-12-31 | 6200.00 | $-2,300.00 | 0.00 |
| 2020-09-30 | 6800.00 | $-3,450.00 | 0.00 |
| 2020-06-30 | 6350.00 | $-4,600.00 | 0.00 |
| 2020-03-31 | 3250.00 | $-5,900.00 | 0.00 |
| 2019-12-31 | 5850.00 | $-6,500.00 | 0.00 |
| 2019-09-30 | 12500.00 | $-6,750.00 | 0.00 |
| 2019-06-30 | 8400.00 | $-6,450.00 | 0.00 |
| 2019-03-31 | 13150.00 | $-6,300.00 | 0.00 |
| 2018-12-31 | 15050.00 | $-6,400.00 | 0.00 |
| 2018-09-30 | 37250.00 | $-4,650.00 | 0.00 |
| 2018-06-30 | 38700.00 | $-5,650.00 | 0.00 |
| 2018-03-31 | 32450.00 | $-6,550.00 | 0.00 |
| 2017-12-31 | 20600.00 | $-7,150.00 | 0.00 |
| 2017-09-30 | 21000.00 | $-9,500.00 | 0.00 |
| 2017-06-30 | 16050.00 | $-9,800.00 | 0.00 |
| 2017-03-31 | 26300.00 | $-10,200.00 | 0.00 |
| 2016-12-31 | 26300.00 | $-10,550.00 | 0.00 |
| 2016-09-30 | 36200.00 | $-11,000.00 | 0.00 |
| 2016-06-30 | 39450.00 | $-11,300.00 | 0.00 |
| 2016-03-31 | 49300.00 | $-11,100.00 | 0.00 |
| 2015-12-31 | 54700.00 | $-11,000.00 | 0.00 |
| 2015-09-30 | 43800.00 | $-10,450.00 | 0.00 |
| 2015-06-30 | 81150.00 | $-11,150.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.007B |
| T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |